Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Onychomycosis Going for cure Gupta AK; Shear NHCan Fam Physician 1997[Feb]; 43 (ä): 299-305OBJECTIVE: To review onychomycosis with an emphasis on the traditional and newer antifungal agents available to treat onychomycosis. QUALITY OF EVIDENCE: We searched MEDLINE for the years 1966 to 1995. We excluded case reports from our analysis. MAIN FINDINGS: For treating onychomycosis, newer antifungal agents (such as terbinafine, itraconazole, and fluconazole) are more cost-effective than the traditional agents griseofulvin and ketoconazole. Of the newer agents, only terbinafine is currently approved in Canada for treating onychomycosis. CONCLUSIONS: The new generation of drugs is an important addition to the armamentarium of therapies available for treating onychomycosis. At the moment, in Canada, terbinafine is the drug of choice and more cost-effective than griseofulvin for treating dermatophyte-induced onychomycosis.|Algorithms[MESH]|Antifungal Agents/economics/*therapeutic use[MESH]|Cost-Benefit Analysis[MESH]|Decision Trees[MESH]|Humans[MESH]|Onychomycosis/diagnosis/*drug therapy[MESH]|Treatment Outcome[MESH] |
